VISA is Required for B Cell Expression of TLR7
Overview
Affiliations
B cells play a critical role in the initialization and development of the systemic lupus erythematosus that is dependent on the expression of the endosomal ssRNA receptor TLR7. Previous studies have established that B cell expression of TLR7 is controlled by the type I IFN secreted by plasmacytoid dendritic cells. In this article, we report that VISA, also known as MAVS, IPS-1, and CardIf, essential for RIG-I/MDA5-mediated signaling following sensing of cytosolic RNA, regulate B cell expression of TLR7 and CD23. We found that B cells from a VISA(-/-) mouse express reduced TLR7 but normal basal levels of type I IFN. We also show that although IFN-β and TLR7 agonists synergize to promote TLR7 expression in VISA(-/-) B cells, they do not fully complement the defect seen in VISA(-/-) cells. Cell transfer experiments revealed that the observed effects of VISA(-/-) are B cell intrinsic. The reduced TLR7 expression in B cells is correlated with impaired TLR7 agonist-induced upregulation of activation markers CD69 and CD86, cell proliferation, production of IFN-α, TNF, and IL-12, and NF-κB activation. Finally, studies indicate that genetic background may influence the observed phenotype of our VISA(-/-) mice, because VISA(-/-) B cells differ in CD23 and TLR7 expression when on C57BL/6 versus 129Sv-C57BL/6 background. Thus, our findings suggest an unexpected link between VISA-mediated cytosolic RLR signaling and autoimmunity.
SOX9 negatively regulates the RLR antiviral signaling by targeting MAVS.
Jiang X, Xu L Virus Genes. 2022; 58(2):122-132.
PMID: 35103914 DOI: 10.1007/s11262-022-01886-9.
Zhang Z, Xiong T, Yao S, Wei M, Chen M, Lin D Nat Commun. 2020; 11(1):5536.
PMID: 33139700 PMC: 7606512. DOI: 10.1038/s41467-020-19318-3.
Antiviral Adaptor MAVS Promotes Murine Lupus With a B Cell Autonomous Role.
Sun W, Wang H, Qi C, Wu J, Scott B, Bolland S Front Immunol. 2019; 10:2452.
PMID: 31681326 PMC: 6805724. DOI: 10.3389/fimmu.2019.02452.
Gomes A, Mohsen M, Mueller J, Leoratti F, Cabral-Miranda G, Bachmann M Front Immunol. 2019; 10:1679.
PMID: 31428084 PMC: 6687836. DOI: 10.3389/fimmu.2019.01679.
Type of RNA Packed in VLPs Impacts IgG Class Switching-Implications for an Influenza Vaccine Design.
Gomes A, Roesti E, El-Turabi A, Bachmann M Vaccines (Basel). 2019; 7(2).
PMID: 31167472 PMC: 6630894. DOI: 10.3390/vaccines7020047.